Plain-English translation of NCT06836453 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Cystic fibrosis is a genetic disease that affects how sweat glands and other organs work. This trial is testing a new device that measures sweat gland function in a different way than the current standard test. The new measurement could help doctors catch borderline cases and better understand how well new cystic fibrosis treatments are working.
The current sweat test for cystic fibrosis doesn't always give clear answers, especially in borderline cases or when patients have unusual genetic mutations. The new testing method measures a different aspect of how sweat glands function, which may be more sensitive and help doctors make clearer diagnoses.
You likely qualify if…
You likely don't qualify if…
You will attend two separate testing sessions, each lasting about 50 minutes. During each session, researchers will use a device called a Macroduct on both your arms to stimulate your sweat glands in two different ways. They will then measure how much you sweat using two different measurement methods. The procedures are non-invasive and use gentle electrical stimulation and sometimes a small injection to trigger sweat production.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
Belgium